Technical Analysis for AVCO - Avalon GloboCare Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
1.67 | 1.21% | 0.02 |
AVCO closed up 1.21 percent on Wednesday, February 19, 2020, on 2.16 times normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Historical AVCO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/03/2019
- Sector: Healthcare
- Industry: Medical Care
Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.
Medicine Diseases Disease Infectious Diseases Immunotherapy Oncology Regenerative Medicine Infectious Disease Exosome Fibrotic Diseases Vesicles
Medicine Diseases Disease Infectious Diseases Immunotherapy Oncology Regenerative Medicine Infectious Disease Exosome Fibrotic Diseases Vesicles
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.63 |
| 52 Week Low | 1.4 |
| Average Volume | 198,311 |
| 200-Day Moving Average | 1.94 |
| 50-Day Moving Average | 1.79 |
| 20-Day Moving Average | 1.61 |
| 10-Day Moving Average | 1.55 |
| Average True Range | 0.12 |
| ADX | 15.14 |
| +DI | 38.69 |
| -DI | 22.99 |
| Chandelier Exit (Long, 3 ATRs ) | 1.59 |
| Chandelier Exit (Short, 3 ATRs ) | 1.76 |
| Upper Bollinger Band | 1.83 |
| Lower Bollinger Band | 1.40 |
| Percent B (%b) | 0.63 |
| BandWidth | 26.33 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.07 |
| MACD Histogram | 0.0088 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.03 | ||||
| Resistance 3 (R3) | 2.07 | 1.99 | 1.97 | ||
| Resistance 2 (R2) | 1.99 | 1.90 | 1.97 | 1.95 | |
| Resistance 1 (R1) | 1.83 | 1.84 | 1.79 | 1.79 | 1.93 |
| Pivot Point | 1.75 | 1.75 | 1.73 | 1.73 | 1.75 |
| Support 1 (S1) | 1.59 | 1.66 | 1.55 | 1.55 | 1.41 |
| Support 2 (S2) | 1.51 | 1.60 | 1.49 | 1.39 | |
| Support 3 (S3) | 1.35 | 1.51 | 1.37 | ||
| Support 4 (S4) | 1.31 |
